3654 results for «372»

Filter By

3654 results

Plaque modification in different lesions types: nodular, long lesions, tortuous lesions, bifurcations

28 Feb 2026 – From Euro4C Annual Meeting 2026

Explore advanced plaque modification strategies tailored to diverse lesion types such as nodular, long, tortuous lesions, and bifurcations. Delve into approaches for managing under-expanded stents and calcified nodules, supported by evidence including results from the French orbital atherectomy registry.

Plaque modification in different lesions types: nodular, long lesions, tortuous lesions, bifurcations

How to avoid and manage complications

28 Feb 2026 – From Euro4C Annual Meeting 2026

Build a comprehensive complication-management toolbox tailored for PCI in heavily calcified vessels. This session covers prevention and management techniques for complications arising from severely calcified lesions, illustrated by practical cases and expert insights into risky lesions and challenging devices.

How to avoid and manage complications

Drug-eluting balloon in calcified lesions and complex lesions

28 Feb 2026 – From Euro4C Annual Meeting 2026

This session explores the application of drug-eluting balloons (DCB) in managing calcified and complex coronary lesions. Emphasis is placed on identifying appropriate lesions for a DCB-only strategy, the critical role of vessel preparation prior to drug delivery, and the long-term physiological assessment following treatment, supported by...

Drug-eluting balloon in calcified lesions and complex lesions

It is a calcified left main: do it well, do it safely

28 Feb 2026 – From Euro4C Annual Meeting 2026

This session addresses the complexities of percutaneous coronary intervention (PCI) in calcified left main coronary artery disease. It covers comprehensive planning including mechanical circulatory support, intravascular imaging, and bifurcation strategies. Attendees will also learn to anticipate and manage potential complications and apply various tools to ensure...

It is a calcified left main: do it well, do it safely

ResilCard - A resilience assessment tool to ensure cardiovascular care continuity during crises

28 Feb 2026 – From Euro4C Annual Meeting 2026

Introducing ResilCard, a novel resilience assessment tool designed to maintain continuity of cardiovascular care during crises. This session highlights the importance of preparedness and adaptive strategies to ensure uninterrupted patient management in challenging healthcare environments.

ResilCard - A resilience assessment tool to ensure cardiovascular care continuity during crises

The best cases of the Euro4C PCRonline website

28 Feb 2026 – From Euro4C Annual Meeting 2026

This session presents some of the most instructive and challenging cases featured on the Euro4C PCRonline website. The cases encompass management of stalled rotational atherectomy burrs, combined use of intravascular lithotripsy and Impella in saphenous vein grafts, complexities of calcium in tortuous anatomy, and strategies for...

The best cases of the Euro4C PCRonline website

Closing Ceremony

28 Feb 2026 – From Euro4C Annual Meeting 2026

The closing ceremony marks the conclusion of the conference, providing a summary of key learnings, acknowledgments, and final reflections on the advancements and discussions presented throughout the event.

Euro4C Annual Meeting 2026 Closing Ceremony

Imaging-guided intravascular lithotripsy for calcified lesions - LIVE case

27 Feb 2026 – From Euro4C Annual Meeting 2026

This live educational case from St. Francis Hospital and Heart Center demonstrates imaging-guided intravascular lithotripsy for calcified lesions. It covers lesion selection criteria, preparation and delivery of lithotripsy catheters, and reviews recent clinical evidence to guide best practices.

LIVE Educational Case from St. Francis Hospital & Heart...

Imaging-guided intravascular lithotripsy for calcified lesions - LIVE case

Coronary sinus reducer for microvascular angina

28 Feb 2020

A 61-year-old man with a history of 2-vessel coronary artery stenting, hypertension and type-2 diabetes mellitus was admitted 5 times within September 2017 and November 2018 for recurrent angina CCS class III-IV refractory to therapy with nitrates, b-blockers and ranolazine in maximally tolerated doses...

Coronary sinus reducer for microvascular angina

OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease

04 Nov 2021

Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
OPTIMUM: Early Outcomes From a Prospective Registry of PCI in Patients at Prohibitive Risk for CABG

Concomitant left atrial appendage occlusion and transcatheter aortic valve replacement among patients with atrial fibrillation – The WATCH-TAVR Trial

26 Oct 2023

Panos Xaplanteris provides his take on WATCH-TAVR results which were presented by Samir R. Kapadia at TCT Congress 2023.

Safety and Efficacy of Left Atrial Appendage Occlusion at the Time of Transcatheter Aortic Valve Replacement - The WATCH TAVR Trial

Panagiotis Xaplanteris

Author

Panagiotis Xaplanteris
Safety and Efficacy of Left Atrial Appendage Occlusion at the Time of Transcatheter Aortic Valve Replacement - The WATCH TAVR Trial

The FLAVOUR Randomized Clinical Trial: Comparison of Fractional Flow Reserve-guided and Intravascular Ultrasound-guided Percutaneous Coronary Intervention in Intermediate Coronary Artery Stenosis

22 Mar 2022

Daniele Giacoppo analyses the main results of the FLAVOUR trial which were presented by Bon-Kwon Koo, from Seoul National University Hospital, South Korea at the American College of Cardiology 2022. 

Daniele Giacoppo

Author

Daniele Giacoppo
The FLAVOUR Randomized Clinical Trial: Comparison of Fractional Flow Reserve-guided and Intravascular Ultrasound-guided Percutaneous Coronary Intervention in Intermediate Coronary Artery Stenosis

Five-year outcomes of the randomised trial of fractional flow reserve guided PCI compared to coronary artery bypass grafting: FAME 3

02 Apr 2025

Kalaivani Mahadevan provides her take on the five-year outcomes of the FAME 3 trial presented by William F. Fearon at ACC.25 in Chicago.

Kalaivani Mahadevan

Author

Kalaivani Mahadevan
FFR-guided PCI vs CABG: 5-year results of the FAME 3 trial

Harmonising optimal strategy for treatment of coronary artery diseases – bleeding risk: HOST-BR

29 Mar 2025

Daniele Giacoppo and Nicola Ammirabile provide their take on the main results of the HOST-BR trial, presented by Hyo-Soo Kim at ACC.25 in Chicago.

Nicola Ammirabile

Author

Nicola Ammirabile
Daniele Giacoppo

Author

Daniele Giacoppo
Harmonising optimal strategy for treatment of coronary artery diseases – bleeding risk: HOST-BR
Didn’t find what you were looking for?